provide the cdc's immunization schedule recommendation for children under the age of 10
- User
provide the cdc's immunization schedule recommendation for children under the age of 10
Assistant
The CDC's 2025 recommended immunization schedule for children under age 10 outlines vaccines and dosing intervals to protect against 16 preventable diseases. Here’s the breakdown by age group:
Birth to 15 Months
-
Hepatitis B (HepB):
- Dose 1 at birth
- Dose 2 at 1–2 months
- Dose 3 at 6–18 months[1][4][7]
-
Rotavirus (RV):
- Dose 1 at 2 months
- Dose 2 at 4 months
- Dose 3 (if using RV5) at 6 months[1][7][10]
-
DTaP (Diphtheria, Tetanus, Pertussis):
- Doses at 2, 4, 6, and 15–18 months
- Final dose at 4–6 years[1][5][7]
-
Haemophilus influenzae type b (Hib):
- Doses at 2, 4, 6, and 12–15 months (depending on vaccine type)[1][7][10]
-
Pneumococcal (PCV15/20):
- Doses at 2, 4, 6, and 12–15 months[1][7][10]
-
Polio (IPV):
- Doses at 2, 4, and 6–18 months
- Final dose at 4–6 years[1][7][10]
-
COVID-19:
- Begin at 6 months with 2024–2025 formula (2–3 doses depending on vaccine brand)[2][4][7]
-
Influenza (Flu):
- Annual vaccination starting at 6 months (2 doses if first-time recipient)[7][10]
12–23 Months
-
MMR (Measles, Mumps, Rubella):
- Dose 1 at 12–15 months[1][7][9]
-
Varicella (Chickenpox):
- Dose 1 at 12–15 months[1][7][9]
-
Hepatitis A (HepA):
- 2-dose series starting at 12 months (dose 2 after 6 months)[1][7][10]
4–6 Years
-
DTaP:
- Final dose at 4–6 years[1][5][7]
-
IPV:
- Final dose at 4–6 years[1][7][10]
-
MMR:
- Dose 2 at 4–6 years[1][7][9]
-
Varicella:
- Dose 2 at 4–6 years[1][7][9]
Catch-Up Guidelines for Delayed Vaccination
- Minimum intervals between doses must be followed (e.g., 4 weeks for most vaccines)[1][4][6].
- No need to restart a series, even if significantly delayed[1][4].
- Special considerations for high-risk conditions (e.g., immunocompromised children may need additional doses)[1][10].
Key Updates for 2025
- COVID-19 vaccines are integrated into the schedule for children ≥6 months[2][3][7].
- Meningococcal vaccines (MenACWY) are recommended for high-risk groups starting at 2 months[1][4].
- RSV monoclonal antibody (Nirsevimab) for infants based on maternal vaccination status[7][10].
For children with missed doses, refer to the CDC’s catch-up schedule to ensure timely protection[1][3][6]. Always consult a healthcare provider to tailor the schedule to individual needs.
-
Other models, same or similar prompt
Responses were produced in different, uncontrolled contexts (system prompts, settings, prior turns). This is not a benchmark.